| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |